āļ¸āˇ–āļŊāˇŠâ€āļē

āļļ⎓āļ§āˇ
āļŊ⎐āļēāˇ’āˇƒāˇŠāļ­āˇ”
āļšāˇœāļ§āˇƒāˇŠ āļ…āļ‚⎁
⎃āļ‚āļšāˇšāļ­
⎃āļ‚āļšāˇšāļ­
āļ¸āˇ’āļŊ
⎀⎙āļąāˇƒāˇŠ āļšāˇ’āļģ⎓āļ¸
% ⎀⎙āļąāˇƒ
āļąāˇāļšāˇ”āļģ⎔⎀
āļ†āˇƒāļąāˇŠāļąāļ­āļ¸ āļ´āˇ™āļģ
āˇ€āˇ’āˇ€āˇ˜āļ­ āļšāļģāļąāˇŠāļą
āļ‰āˇ„⎅
āļ´āˇ„⎅
⎄āļŦ āļ´āļģ⎒āļ¸āˇāļĢāļē
⎀⎙.āļ´āˇœ āļ´āˇŠâ€āļģāˇāļœāˇŠāļ°āļąāļē
SIXB
Materials
SIXB
Materials
SIXB
-0.62%
1,086.07
-6.73
-0.62%
—1,092.801,093.681,094.851,085.07——
SIXC
Communications
SIXC
Communications
SIXC
-0.13%
603.98
-0.76
-0.13%
—604.74604.74605.10601.66——
SIXE
Energy
SIXE
Energy
SIXE
+1.20%
1,229.41
+14.61
+1.20%
—1,214.801,220.811,233.621,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.61%
1,714.02
-10.55
-0.61%
—1,724.571,727.021,732.301,713.27——
SIXM
Financials
SIXM
Financials
SIXM
+0.20%
640.71
+1.28
+0.20%
—639.43641.58644.53638.07——
SIXR
Staples
SIXR
Staples
SIXR
-0.55%
834.52
-4.63
-0.55%
—839.15836.90838.79832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
214.17
-1.45
-0.67%
—215.62215.62216.21214.07——
SIXT
Technology
SIXT
Technology
SIXT
+0.70%
3,201.79
+22.27
+0.70%
—3,179.523,191.503,205.073,178.28——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.58%
931.49
-5.42
-0.58%
—936.91935.42937.17930.20——
SIXV
Health care
SIXV
Health care
SIXV
-1.18%
1,435.59
-17.18
-1.18%
—1,452.771,445.931,446.241,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.14%
2,362.13
-3.05
-0.14%
—2,365.182,353.642,368.102,348.51——
CVG:FRA
CSPC Pharmaceutical Group Ltd
â‚Ŧ0.89
-0.71%
(-0.0064) 1D
āļļāļšāˇŠ 29, 08.04.00 āļœāˇŠâ€āļģ⎒āļ¸āˇ€āˇš+2  ·   EUR
āˇƒāˇ’āļēāļŊ⎔ ⎃āļ‚āļšāˇšāļ­
⎃āļ‚āļšāˇšāļ­āļēāļ¸āˇ’āļŊ⎀⎙āļąāˇƒāˇŠ āļšāˇ’āļģ⎓āļ¸% ⎀⎙āļąāˇƒ
CVG ⎃āļŗāˇ„āˇ āļ‰āˇ„⎅āļ¸ āļ‡āļ­āˇ”āˇ…āˇāļąāˇŠāļ­āļēāļąāˇŠ āļ‹āļ­āˇŠāļ´āˇāļ¯āļąāļē āļšāļģāļ¸āˇ’āļąāˇŠ...
āˇ€āˇ’āˇ€āˇ˜āļ­ āļšāļģāļąāˇŠāļą
â‚Ŧ0.89
āļ‰āˇ„⎅
â‚Ŧ0.89
āļ´āˇ„⎅
â‚Ŧ0.89
⎀⎙.āļ´āˇœ āļ´āˇŠâ€āļģāˇāļœāˇŠāļ°āļąāļē
āļļ⎒96.79
āļ¯āˇ… āļ´āļģ⎒āļ¸āˇāˇ€
307.00
⎄āļŦ āļ´āļģ⎒āļ¸āˇāļĢāļē
0.00
⎃āļ­āˇ’-52 āļ‰āˇ„⎅
â‚Ŧ1.25
⎃āļ­āˇ’-52 āļ´āˇ„⎅
â‚Ŧ0.63
āˇƒāˇšāˇ€āļšāļē⎒āļąāˇŠ āļœāļĢāļą
āļ¯20
āļ´āˇ”⎀āļ­āˇŠ āˇƒāˇ„ āļšāļŽāˇ
⎀⎙āļļāļē ⎄āļģāˇ„āˇ āļ¸āˇ–āļŊāˇāˇāˇŠâ€āļģ ⎀⎙āļ­āˇ’āļąāˇŠ
TipRanks
TipRanks
·
āļ´āˇāļē 3āļšāļ§ āļ´āˇ™āļģ
CSPC Wins U.S. and China Trial Approvals for New Oncology Antibody-Drug Conjugate
TipRanks
TipRanks
·
āļ´āˇāļē 3āļšāļ§ āļ´āˇ™āļģ
CSPC Wins Historic EU Approval for Chinese-Made Liposomal Antifungal
āļ´āˇāļ­āˇ’āļšāļŠ
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
CSPC Pharmaceutical Group Ltd āļœāˇāļą
CEOZhang Cuilong
āˇƒāˇšāˇ€āļšāļē⎒āļąāˇŠāļ¯19.7
āļ†āļģāļ¸āˇŠāļˇ āļšāˇ…āˇš1992
āļ¸āˇ–āļŊ⎃⎊āļŽāˇāļąāļē-
āļ…āļ‚⎁āļē-
⎀⎙āļļ⎊ āļ…āļŠāˇ€āˇ’āļēcspc.com.hk
āļ´āˇ™āļģ āˇ€āˇāļģ⎊āļ­āˇHKD ⎄⎒ āˇƒāˇ’āļēāļŊ⎔ āļ…āļœāļēāļąāˇŠ
Loading Previous Earnings...
āļ†āļ¯āˇāļēāļ¸āˇŠ āļ´āˇŠâ€āļģāļšāˇāˇāļē
āļ†āļ¯āˇāļēāļ¸
⎁⎔āļ¯āˇŠāļ° āļ†āļ¯āˇāļēāļ¸
CNY ⎄⎒ āˇƒāˇ’āļēāļŊ⎔ āļ…āļœāļēāļąāˇŠ
2025 āļ¸āˇāļ¯āˇ’āļąāˇŠ
2025 āļ´āˇœāˇƒāˇœāļąāˇŠ
2025 āļļ⎒āļąāļģ
2025 āļ‹āļŗāˇ”⎀āļ´āˇŠ
āļ†āļ¯āˇāļēāļ¸
āļļ⎒7.01
āļļ⎒6.26
āļļ⎒6.62
āļļ⎒6.11
⎀⎒āļšāˇ”āļĢāļą āļŊāļ¯ āļˇāˇāļĢ⎊āļŠāˇ€āļŊ āļ´āˇ’āļģ⎒⎀⎐āļē
āļļ⎒2.31
āļļ⎒2.25
āļļ⎒2.28
āļļ⎒2.11
āļ†āļ¯āˇāļēāļ¸āˇŠ āļ´āˇ’āļģ⎒⎀⎐āļē
āļļ⎒2.31
āļļ⎒2.25
āļļ⎒2.28
āļļ⎒2.11
āļ´āļģ⎊āļēāˇšāˇ‚āļĢ āˇƒāˇ„ ⎃āļ‚⎀āļģ⎊āļ°āļą āˇ€āˇ’āļēāļ¯āļ¸āˇŠ
āļļ⎒1.30
āļļ⎒1.38
āļļ⎒1.50
āļļ⎒1.62
āļ¸āˇ”⎅⎔ āļ´āļģ⎊āļēāˇšāˇ‚āļĢ āˇƒāˇ„ ⎃āļ‚⎀āļģ⎊āļ°āļą āˇ€āˇ’āļēāļ¯āļ¸āˇŠ
-
-
-
-
⎀⎒āļšāˇ’āļĢ⎓āļ¸, āˇƒāˇāļ¸āˇāļąāˇŠâ€āļē, āˇƒāˇ„ āļ´āļģ⎒āļ´āˇāļŊāļą āˇ€āˇ’āļēāļ¯āļ¸āˇŠ
āļļ⎒1.89
āļļ⎒1.56
āļļ⎒1.97
āļļ⎒1.87
āļ¸āˇ™āˇ„⎙āļē⎔āļ¸āˇŠ ⎀⎒āļēāļ¯āļ¸
āļļ⎒3.19
āļļ⎒2.94
āļļ⎒3.47
āļļ⎒3.49
āļ¸āˇ”⎅⎔ āļ¸āˇ™āˇ„⎙āļē⎔āļ¸āˇŠ ⎀⎒āļēāļ¯āļ¸āˇŠ
āļļ⎒5.50
āļļ⎒5.20
āļļ⎒5.75
āļļ⎒5.60
āļ¸āˇ™āˇ„⎙āļē⎔āļ¸āˇŠ āļ†āļ¯āˇāļēāļ¸
āļļ⎒1.51
āļļ⎒1.06
āļ¸āˇ’869.63
āļ¸āˇ’514.71
⎀⎙āļąāļ­āˇŠ āļ¸āˇ™āˇ„⎙āļē⎔āļ¸āˇŠ āļąāˇœāˇ€āļą āļ†āļ¯āˇāļēāļ¸
āļ¸āˇ’278.47
āļ¸āˇ’3.60
āļ¸āˇ’645.49
-āļ¸āˇ’470.42
āļ…āˇƒāˇāļ¸āˇāļąāˇŠâ€āļē āļ…āļē⎒āļ­āļ¸ āļ‡āļ­āˇ”⎅⎔⎀ EBT
āļļ⎒1.80
āļļ⎒1.32
āļļ⎒1.18
āļ¸āˇ’505.59
āļ…āˇƒāˇāļ¸āˇāļąāˇŠâ€āļē āļ…āļē⎒āļ­āļ¸ āˇ„āˇāļģ EBT
āļļ⎒1.80
āļļ⎒1.14
āļļ⎒1.37
āļ¸āˇ’186.56
āļ†āļ¯āˇāļēāļ¸āˇŠ āļļāļ¯āˇ” ⎀⎒āļēāļ¯āļ¸
āļ¸āˇ’301.26
āļ¸āˇ’242.36
āļ¸āˇ’222.47
āļ¸āˇ’165.64
āļĩāļŊāļ¯āˇāļē⎓ āļļāļ¯āˇ” āļ…āļąāˇ”āļ´āˇāļ­āļē
16.77%
18.34%
18.78%
32.76%
⎀⎙āļąāļ­āˇŠ āļ¸āˇ™āˇ„⎙āļē⎔āļ¸āˇŠ ⎀⎒āļēāļ¯āļ¸āˇŠ
-
-
-
-
⎁⎔āļ¯āˇŠāļ° āļ†āļ¯āˇāļēāļ¸
āļļ⎒1.48
āļļ⎒1.07
āļ¸āˇ’963.54
āļ¸āˇ’370.72
⎁⎔āļ¯āˇŠāļ° āļŊāˇāļˇ āļ†āļąāˇŠāļ­āˇ’āļšāļē
21.07%
17.09%
14.56%
6.06%
āļšāˇœāļ§āˇƒāļšāļ§ āļ‰āļ´āˇāļē⎓āļ¸āˇŠ
-
-
-
-
āļ´āˇœāļŊ⎓ āˇƒāˇ„ āļ†āļēāˇāļĸāļą āļ†āļ¯āˇāļēāļ¸
-
āļ¸āˇ’95.00
-
āļ¸āˇ’195.87
āļ´āˇœāļŊ⎓ ⎀⎒āļēāļ¯āļ¸
-āļ¸āˇ’6.74
-āļ¸āˇ’14.91
-āļ¸āˇ’105.19
-āļ¸āˇ’6.76
⎁⎔āļ¯āˇŠāļ° āļ´āˇœāļŊ⎓ ⎀⎒āļēāļ¯āļ¸āˇŠ
-āļ¸āˇ’6.74
āļ¸āˇ’80.09
-āļ¸āˇ’105.19
āļ¸āˇ’189.12
āļ…⎀āļ´āˇŠâ€āļģāļ¸āˇāļĢāļē āˇƒāˇ„ āļ†āļ´āˇƒāˇ” āļœāˇ™āˇ€āˇ“āļ¸āˇš āļœāˇāˇƒāˇŠāļ­āˇ”
-
-
-
-
EBITDA
āļļ⎒1.79
āļļ⎒1.36
āļļ⎒1.14
āļ¸āˇ’785.97
⎀āļ­āˇŠāļšāļ¸āˇŠ ⎀⎒āļšāˇ’āļĢ⎓āļ¸āˇ™āļąāˇŠ āļŊāˇāļˇāļē āˇ„āˇ āļ…āļŊāˇāļˇāļē
-
-
-
-
AI āļ…āļąāˇŠāļ­āļģ⎊āļœāļ­āļē⎚ ⎀⎐āļģāļ¯āˇ’ āļ‡āļ­āˇ”⎅āļ­āˇŠ ⎀⎒āļē ⎄⎐āļš. āļ­āˇ€ āļ¯āˇāļą āļœāļąāˇŠāļą

āļ´āļģ⎊āļēāˇšāˇ‚āļĢāļē

āļ¸āļœāˇš āļšāˇāļģ⎊āļē
āļ”āļļ āļ­āˇ€āļ¸āļ­āˇŠ āļšāˇāļģ⎊āļēāļēāļšāˇŠ āļąāˇ’āļģ⎊āļ¸āˇāļĢāļē āļšāļģ āļąāˇāļ­
āļ”āļļ⎚ āļšāˇāļģ⎊āļēāļēāļąāˇŠ āļ¸āˇ™āˇ„⎒ āļ¯āˇ’āˇƒāˇŠ ⎀āļąāˇ” āļ‡āļ­. āļšāˇāļģ⎊āļēāļēāļąāˇŠ āļšāˇāļŊ⎃āļ§āˇ„āļąāˇŠāļœāļ­ āļšāļģ āļ”āļļ āļąāˇœāļ¸āˇāļ­āˇ’ ⎀⎒āļ§ Google Finance ⎀⎐āļŠāļ§ āļ¯āļ¸āļąāˇŠāļą.
āļ†āļšāˇ˜āļ­āˇ’
āļąāˇāļģāļšāˇ”āļ¸āˇŠ āļŊ⎐āļēāˇ’āˇƒāˇŠāļ­āˇ” āˇƒāˇāļģāˇāļ‚⎁āļē
āļ”āļļ⎚ āļąāˇāļģāļšāˇ”āļ¸āˇŠ āļŊ⎐āļēāˇ’āˇƒāˇŠāļ­āˇ”āˇ€āˇš āļ¯āˇ›āļąāˇ’āļš āˇ€āˇ™āˇ…āļŗāļ´āˇœāˇ…āļ§ āļ´āˇ™āļģ āˇ€āˇ’āˇāˇŠāļŊāˇšāˇ‚āļĢāļēāļšāˇŠ
āļ‰āļ¯āˇ’āļģ⎒āļēāļ§ āļ‘āļą āļ‰āļ´āˇāļē⎓āļ¸āˇŠ
⎃āļ­āˇ’āļē āļ­āˇ”⎅ āļ‰āļ¯āˇ’āļģ⎒āļēāļ§ āļ‘āļą āļ‰āļ´āˇāļē⎓āļ¸āˇŠ āˇ€āˇāļģ⎊āļ­āˇ
āļ…āˇƒāˇāļ¸āˇāļąāˇŠâ€āļē āļ…āˇƒāˇŠāļŽāˇāˇ€āļģāļ­āˇŠāˇ€āļē āˇƒāˇ„ āļ´āļģ⎒āļ¸āˇāˇ€
āļ…āļ¯ āļ…āˇƒāˇŠāļŽāˇāˇ€āļģāļ­āˇŠāˇ€āļē āˇƒāˇ„ āļ´āļģ⎒āļ¸āˇāˇ€ āļ´āˇ’⎅⎒āļļāļŗ āļ¸āˇ”āļŊ⎊ āļ…āļąāļ­āˇ”āļģ⎔ āļ‡āļŸāˇ€āˇ“āļ¸
AI āļ…āļąāˇŠāļ­āļģ⎊āļœāļ­āļē⎚ ⎀⎐āļģāļ¯āˇ’ āļ‡āļ­āˇ”⎅āļ­āˇŠ ⎀⎒āļē ⎄⎐āļš. āļ­āˇ€ āļ¯āˇāļą āļœāļąāˇŠāļą